Biotechnology is moving at lightening speed, especially with the advances in genetic engineering and synthetic biology. However, policies and regulations lag far behind, leaving potentially dangerous gaps in classification and oversight.

Dr. Jennifer Kuzma, GES Co-Director, who works on issues of regulation and governance of GMOs and synthetic biology, shares her concerns in Slate.